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Abstract
Background: The human innate immune system relies on the coordinated activity of macrophages and polymorphonuclear
leukocytes (neutrophils or PMNs) for defense against bacterial pathogens. Yersinia spp. subvert the innate immune response
to cause disease in humans. In particular, the Yersinia outer protein YopJ (Y. pestis and Y. pseudotuberculosis) and YopP (Y.
enterocolitica) rapidly induce apoptosis in murine macrophages and dendritic cells. However, the effects of Yersinia Yop J/P
on neutrophil fate are not clearly defined.
Methodology/Principal Findings: In this study, we utilized wild-type and mutant strains of Yersinia to test the contribution
of YopJ and YopP on induction of apoptosis in human monocyte-derived macrophages (HMDM) and neutrophils. Whereas
YopJ and YopP similarly induced apoptosis in HMDMs, interaction of human neutrophils with virulence plasmid-containing
Yersinia did not result in PMN caspase activation, release of LDH, or loss of membrane integrity greater than PMN controls.
In contrast, interaction of human PMNs with the virulence plasmid-deficient Y. pestis strain KIM6 resulted in increased
surface exposure of phosphatidylserine (PS) and cell death. PMN reactive oxygen species (ROS) production was inhibited in
a virulence plasmid-dependent but YopJ/YopP-independent manner. Following phagocytic interaction with Y. pestis strain
KIM6, inhibition of PMN ROS production with diphenyleneiodonium chloride resulted in a reduction of PMN cell death
similar to that induced by the virulence plasmid-containing strain Y. pestis KIM5.
Conclusions: Our findings showed that Yersinia YopJ and/or YopP did not induce pronounced apoptosis in human
neutrophils. Furthermore, robust PMN ROS production in response to virulence plasmid-deficient Yersinia was associated
with increased PMN cell death, suggesting that Yersinia inhibition of PMN ROS production plays a role in evasion of the
human innate immune response in part by limiting PMN apoptosis.
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Introduction
The cellular arm of the human innate immune system includes
the myeloid progenitor-derived mononuclear and polymorphonu-
clear phagocytes, which recognize and eliminate a diverse array of
bacterial pathogens. The mononuclear phagocytes (monocytes,
macrophages and dendritic cells) produce proinflammatory
cytokines and are capable of presenting antigen to CD4+ T cells
via class II MHC [1]. Polymorphonuclear leukocytes (neutrophils
or PMNs) are the most abundant circulating leukocyte and
essential for removal of pathogens [2]. PMNs are recruited to sites
of infection and rapidly phagocytose invading microbes. Following
phagocytosis, PMNs destroy pathogens by releasing highly
microbicidal NADPH oxidase-derived reactive oxygen species
(ROS) and a broad array of potent antimicrobial components into
the pathogen-containing vacuoles [2]. Uptake of bacteria induces
a form of PMN cell death termed phagocytosis-induced cell death
(PICD) that is dependent upon ROS production and is important
for resolution of infection and inflammation [3–8]. Macrophage
clearance of apoptotic PMNs prevents release of cytotoxic granule
components and limits subsequent damage to surrounding
healthy tissues [2,4,6–8]. Overall, the innate immune system is
highly efficient and essential for human health and subversion of
the innate immune system is linked to increased bacterial
pathogenicity [9].
The genus Yersinia contains three species pathogenic for humans
and rodents (Y. enterocolitica, Y. pseudotuberculosis, and Y. pestis). Y.
enterocolitica and Y. pseudotuberculosis are transmitted by fecal-oral
route and cause gastrointestinal syndromes, lymphadenitis, and
septicemia [10]. Y. pestis is typically transmitted through the bite of
an infected flea and causes bubonic and/or septicemic plague
[11]. Alternatively, a rare but highly lethal pneumonic form of
plague may result following inhalation of aerosolized droplets
containing Y. pestis [11]. Despite epidemiologic differences, Yersinia
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virulence plasmid termed pCD1 in Y. pestis and pYV in Y.
enterocolitica and Y. pseudotuberculosis. The Yersinia virulence plasmid
encodes a type III secretion system (TTSS) and 6 known effector
proteins termed Yersinia outer proteins (Yops) [11]. In vivo, Y. pestis
injects Yops into host immune cells with a preference for dendritic
cells, macrophages, and PMNs [12]. Once within the cell, the Yop
proteins cooperatively interfere with host cell signal transduction
pathways [13]. In particular, the effector protein YopJ (YopP in Y.
enterocolitica) has been shown to be an acetyltransferase [14–16], a
deubiquitinating cysteine protease [17,18], and required for
cleavage of the caspase-8 substrate BID [19]. Yersinia YopJ and
YopP have been shown to rapidly activate programmed cell death
(apoptosis) in macrophages and dendritic cells, but not human
epithelial cells [19–27]. Sequence polymorphisms in the N-
terminus of the YopJ/YopP proteins result in higher host cell
translocation efficiency of YopP compared to YopJ [28,29]. The
increased delivery of YopP results in increased J774A.1 macro-
phage and dendritic cell death [28,29]. Increased host cell
cytotoxicity attenuates Yersinia infection in mice [28,30], indicating
that a controlled level of immune cell apoptosis is required for
Yersinia virulence. However, Y. pestis induction of apoptosis in
human PMNs and human monocyte-derived macrophages
(HMDMs) has not been investigated directly. Thus, we evaluated
human PMN and HMDM cell fate following incubation with
Yersinia expressing YopJ or YopP. Our findings show that YopP
and (to a lesser extent) YopJ are cytotoxic to HMDMs but not
human PMNs. Furthermore, Yersinia TTSS-dependent inhibition
of human PMN ROS production is associated with reduced PMN
apoptosis. Reduction of PMN apoptosis potentially delays the
acute inflammatory response and facilitates Yersinia persistence via
intracellular and extracellular survival [31,32] at the site of
infection.
Materials and Methods
Ethics Statement
Human monocytes and PMNs were isolated from heparinized
venous blood of healthy donors in accordance with a protocol
approved by the University of Idaho Institutional Review Board
for Human Subjects (approval number 05-056). Donors were
informed of the procedure risks and provided written consent prior
to enrollment.
Macrophage and PMN Cell Isolation and Culture
The murine macrophage-like cell line J774A.1 cells were
cultured at 37uC under 5% CO2 in Dulbecco’s Modified Eagle
Medium (DMEM; Invitrogen, Carlsbad, CA) supplemented with
10% heat-inactivated fetal bovine serum (FBS; Thermo Fisher
Scientific, Waltham, MA), 100 U/ml penicillin, 100 mg/mL
streptomycin, and 2 mM L-glutamine (Invitrogen). For HMDM
isolation, freshly isolated heparinized human blood was underlaid
with an equal volume of Ficoll-Paque PLUS (Amersham
Biosciences, Piscataway, NJ), and centrifuged at 4856g for
25 min. The buffy coat layer was removed by aspiration and
diluted with Dulbecco’s Phosphate Buffered Saline (DPBS;
Invitrogen). The mixture was centrifuged for 25 min at 2166g
and the cell pellet suspended in RPMI medium 1640 (Invitrogen)
supplemented with 10% FBS, 100 U/ml penicillin, 100 mg/mL
streptomycin, and 2 mM L-glutamine (Invitrogen). Cells were
allowed to adhere and differentiate for 4–6 days at 37uC under 5%
CO2 in tissue culture flasks. HMDM purity was determined by
staining with CD14 and CD68 antibodies conjugated to
phycoerythrin (Invitrogen) and analysis by flow cytometry
(FACSCalibur, BD Biosciences, San Jose, CA) as described
previously [33]. HMDM preparations routinely contained 90%–
97% HMDMs. Human PMN isolation was performed as
described previously [32]. PMNs were isolated fresh the day of
the assay and seeded into autologous normal human serum (NHS)-
coated wells of 96 well tissue culture plates. J774A.1 cells and
HMDMs were washed, enumerated, and seeded into wells of 96
well tissue culture plates ,15 hours prior to the start of each
experiment in antibiotic free RPMI 1640 supplemented with 10%
FBS. Immediately prior to the assay, J774A.1 cells and HMDMs
were washed and medium was replaced with RPMI 1640
supplemented with 2.0% FBS.
Bacterial Strains and Culture Conditions
Liquid cultures of Yersinia were grown at 37uC from viable
frozen stocks and routinely verified as previously described [32].
Strains used were: Y. enterocolitica 8081v (pYV+), and the Y. pestis
strains KIM5 (pCD1+), KIM5 YopJ-YopP (pCD1+, yopJ replaced
with Y. enterocolitica yopP), KIM5DyopJ (pCD1+, DyopJ), and KIM6
(pCD1-). For assays using J774A.1 cells and HMDMs, bacteria
were washed and re-suspended in RPMI 1640 supplemented with
2% FBS. For assays using PMNs, bacteria were opsonized in 5%
NHS. For all experiments, opsonized bacteria were added to
leukocytes (50:1 ratio) in 96-well tissue culture plates and
centrifuged at 1306g for 3 min to synchronize phagocytosis
(represents initial time 0 [T0]). Plates were incubated for 1 h at
37uC under 5% CO2 before addition of gentamicin (100 mg/mL)
to inhibit extracellular bacterial growth.
Generation of Y. pestis KIM5DyopJ Deletion Mutant Strain
The KIM5DyopJ gene deletion strain was created using a
modified Red recombinase system as described previously [31,34].
The YopJ gene deletion cassette was generated by PCR using
primers YopJKOF and YopJKOR (Table 1), and pKD4 as the
template [34]. The kanamycin resistance gene was removed by the
FLP site-specific recombinase encoded on pCP20 (cured by
growth at 39uC) as described [34]. The KIM5DyopJ gene deletion
strain was verified by PCR, sequencing (Sequetech, Mountain
View, CA), and western blot analysis with a YopJ/YopP affinity-
purified polyclonal antibody (rabbit) raised using the conserved
peptide sequence CLSDGENPLPHDKLD (GenScript Corpora-
tion, Piscataway, NJ). The confirmed DNA sequence was
deposited into GenBank (GU066315).
Y. pestis KIM5 YopJ-YopP Open Reading Frame Exchange
Exchange of Y. pestis KIM5 YopJ with Y. enterocolitica 8081v
YopP was by double homologous recombination. The YopP gene
was amplified from Y. enterocolitica 8081v using primers YopPF and
YopPR (Table 1). The amplified YopP gene was cloned into the
pGEM-T Easy Vector (Promega, Madison, WI). The kanamycin
resistance cassette from pKD4 [34] was amplified using primers
kanRF and kanRR (Table 1). The pGEM-T Easy Vector
containing YopP and the amplified kanamycin resistance gene
were digested with SalI (NEB, Ipswich, MA) and SacI (Fermentas,
Glen Burnie, MD) and ligated. Successful ligation created a
pGEM-T Easy Vector with the YopP open reading frame
immediately upstream of the kanamycin resistance gene. YopP-
kanamycin, flanked by 36-nt of homology to the open reading
frame of YopJ, was PCR amplified from the modified pGEM-T
Easy Vector using primers YopP/J-kanRF and YopP/J-kanRR
(Table 1). The YopJ replacement cassette was electroporated into
Y. pestis KIM5 containing pKD46 [34]. Double homologous
recombination was selected for by kanamycin resistance and
verified by PCR and DNA sequencing. Plasmid pKD46 was cured
Yersinia and PMN Cell Death
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removed by an FLP site-specific recombinase [34]. The final Y.
pestis KIM5 strain expressing Y. enterocolitica YopP in place of native
YopJ was verified by PCR and DNA sequencing (GenBank
GU066314) using primers upstream and downstream of the YopJ
locus, and internal YopP-specific primers. Western blot analysis
was performed with a YopJ-YopP affinity-purified polyclonal
antibody as described above.
Cell Cytotoxicity and Membrane Integrity Assays
Cell lysis was quantified by lactose dehydrogenase (LDH)
activity using the Cytotoxicity Detection Kit
Plus (Roche Applied
Science, Indianapolis, IN). Cell membrane integrity was measured
using the LIVE/DEAD Viability/Cytotoxicity Kit for mammalian
cells (Invitrogen) per manufacturer’s instructions. Briefly, 2610
4
cells (J774A.1, HMDMs, or PMNs)/assay were seeded into wells
prior to addition of bacteria. Cells were allowed to incubate for 3–
48 h. LDH activity was measured with a microplate fluorometer
(SpectraMax M2; Molecular Devices, Sunnyvale, CA). For
membrane integrity, ethidium homodimer-1 (EthD-1; 4.5 mM
final concentration) was added at the indicated time points and
allowed to incubate for 30 min at room temp. Fluorescence was
measured using a microplate fluorometer, excitation and emission
of 530 and 645 nm, respectively. The percent LDH release and
the percent membrane integrity was calculated using the formula:
(experimental release – T0 background)/(maximum release – T0
background) 6100. The T0 background control represents the
amount of fluorescence from samples immediately after seeding of
cells. The maximum release represents the value from detergent-
lysed cells. Experiments were repeated at least three times in
triplicate.
Annexin V Staining of PMNs
PMN phosphatidylserine (PS) externalization at indicated time
points was measured with annexin V-FITC (Annexin V-FITC
Apoptosis Detection kit II; BD Biosciences, San Jose, CA) as
described previously [32].
Measurement of Caspase Activity
Caspase-3, -8, -9, and -2 activity were measured with ApoAlert
caspase profiling plates (Clontech Laboratories, Mountain View,
CA) per manufacturer’s instructions. Briefly, J774A.1 cells,
HMDMs, or PMNs were seeded at 2610
5 cells/well prior to
addition of bacteria. Incubation was continued for 3, 6, or 24 h.
Fluorescence of the lysed cellular supernatants in the ApoAlert
caspase profiling plates was read in a microplate fluorometer, by
use of excitation and emission wavelengths of 380 and 460 nm,
respectively.
Assay for PMN Reactive Oxygen Species (ROS) Production
PMN ROS production was measured using a published
fluorometric method as previously described [32]. Inhibition of
PMN ROS production with diphenyleneiodonium chloride (DPI;
Sigma-Aldrich, Saint Louis, MO) was performed as described [35].
Statistics
Statistics were performed with a one-way ANOVA with Tukey’s
post test using GraphPad Prism, version 5.0 for Windows
(GraphPad Software, San Diego, CA). Differences were declared
at P,0.05.
Results
Yersinia YopJ/YopP-Dependent J774A.1 and HMDM Cell
Death
To evaluate a role for YopJ and YopP in induction of cell death,
we measured LDH release and membrane integrity via EthD-1
staining in the murine J774A.1 cell line and HMDMs following
interaction with Yersinia. Incubation of J774A.1 cells or HMDMs
with KIM5, Y. enterocolitica, or KIM5 YopJ-YopP resulted in YopJ-
or YopP-dependent LDH release and EthD-1 staining (Fig. 1);
however, HMDM cell death was delayed between 24–48 h of
incubation compared to J774A.1 cells (Fig. 1c and 1d). In contrast,
KIM6 or KIM5DyopJ incubation with J774A.1 cells or HMDMs
resulted in decreased LDH release and EthD-1 staining (Fig. 1, e.g.,
at 24 h KIM5 and Y. enterocolitica induced 98.263.2% and
98.261.9% of J774A.1 LDH release, respectively, compared to
KIM5DyopJ and KIM6 which induced 42.5611.4% and
43.9613.0% of J774A.1 LDH release, respectively).
Yersinia YopJ/YopP Induces Caspase Activation in
J774A.1 Macrophages and HMDMs
To assess the association of YopJ and YopP with caspase
activation in macrophages, we measured caspase-3, -8, -9, and -2
activity following 3 h (data not shown) and 6 h incubation with
Yersinia. All caspases tested were rapidly activated in J774A.1
macrophages after incubation with KIM5, Y. enterocolitica, or KIM5
YopJ-YopP but not KIM6 or KIM5DyopJ (Fig. 2). HMDMs
incubated with Yersinia did not result in activation of any caspase
tested until ,6 h (Fig. 2). At 6 h, all caspases tested were activated
in HMDMs by YopJ/YopP expressing strains but not by KIM6 or
KIM5DyopJ (Fig. 2). Delayed caspase activation by YopJ/YopP in
Table 1. Oligonucleotides used in this study.
Name Sequence (59-39)
YopJKOF ATGATCGGACCAATATCACAAATAAATATCTCCGGTGTGTAGGCTGGAGCTGCTTC
YopJKOR TTATACTTTGAGAAGTGTTTTATATTCAGCTATTCTCATATGAATATCCTCCTTAG
YopPF AAGCTTGTGCTGCCCGTCTGTTCCGGG
YopPR CCAGTGCGTGGGACAGGCAGGCAATCCGGAGCG
kanRF TCCGTGTCGACGTGTAGGCTGGAGCTGCTTC
kanRR ACGGAGAGCTCCATATGAATATCCTCCTTAG
YopP/J-kanRF TAGGTATGATAGGAGTTATTGGGAATTTTTGTTCGAGTGCTGCCCGTCTGTTCCGG
YopP/J-kanRR GATTCCGGCGTAGAACCCCAGTTAATCTGTTTCTTCCATATGAATATCCTCCTTAG
doi:10.1371/journal.pone.0009279.t001
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delays in HMDM lysis and EthD-1 staining (Fig. 1).
Effects of YopJ/YopP on Neutrophil Viability
To determine if YopJ/YopP was associated with increased cell
death in human PMNs, we measured PMN LDH release and
membrane integrity following incubation with Yersinia. There was
no difference (P.0.05) in PMN LDH release (Fig. 3a) or EthD-1
staining (Fig. 3b) with any of the strains tested following 3 to 6 h of
incubation with Yersinia. After 24 h of incubation, KIM6 showed an
increaseinPMNLDHreleaseand EthD-1stainingcomparedtothe
PMNcontrol(Fig.3aand 3b,e.g.,KIM6induced24.262.4%LDH
release and 25.168.6% EthD-1 staining compared to PMNs which
exhibited 13.268.5% LDH release and 12.567.3% EthD-1
staining). However, none of the virulence plasmid-containing
strains showed an increase in LDH release (Fig. 3a) or EthD-1
staining (Fig. 3b). After 48 h, KIM6 remained the only strain that
induced PMN LDH release (61.062.9%) or EthD-1 staining
(44.063.8%) compared to the PMN control (Fig. 3a and 3b).
Effects of YopJ/YopP on PMN Phosphatidylserine (PS)
Exposure
To further assess PMN cell viability, we measured externaliza-
tion of PS to the outer leaflet of the PMN plasma membrane (an
early indicator of apoptosis) by flow cytometry analysis of annexin
V binding. After 3 h, PMNs incubated with all Yersinia strains
resulted in ,25% annexin V positive cells (Fig. 4) and there was
no difference (P.0.05) in annexin V staining among strains. After
9 h of incubation, the percentage of annexin V positive PMNs
incubated with any of the virulence plasmid containing strains did
not increase from 6 h; however, there was a ,22% increase in
PMNs stained by annexin V following incubation with KIM6
(54.0613.4%) compared to the PMN control (31.861.6%) or
KIM5 (39.0614.5%) (Fig. 4).
Figure 1. Role of YopJ and YopP in J774A.1 macrophage-like and human MDM cell death. Y. pestis strains with the virulence plasmid
expressing YopJ (KIM5), YopP (KIM5 YopJ-YopP), or lacking YopJ (KIM5DyopJ), along with Y. enterocolitica 8081v and the virulence plasmid–deficient
strain (KIM6) were grown at 37uC to induce expression of the TTSS and Yops. Yersinia strains were combined with J774A.1 and HMDM cells and
compared to detergent lysed controls as described in Materials and Methods. The percentage of J774A.1 cell death following incubation alone or
with Yersinia strains at the indicated time was determined by (A) LDH release into the supernatant and by (B) EthD-1 staining of J774A.1 cells. HMDM
cell death was determined by measuring (C) LDH release and (D) EthD-1 uptake into HMDMs. The results are expressed as the mean 6 SEM of at least
three experiments. *, represents difference from J774A.1 or HMDM controls (P,0.05).
doi:10.1371/journal.pone.0009279.g001
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To determine if PMN caspase activation occurs similar to
macrophages following interaction with Yersinia, we measured
PMN caspase-3, -8, -9, and -2 activity after 3 and 6 h of
incubation with Yersinia. PMNs incubated with anti-Fas antibody
were included as a positive control [36]. At 3 h, there was no
difference (P.0.05) among any strain tested and the PMN control
(Fig. 5). At 6 h, there was a 2–3 fold increase in caspase activity
due to anti-Fas antibody (Fig. 5). After 6 h, caspase activity in
PMNs incubated with any of the Yersinia strains was less than or
equal to the PMN control (P.0.05) (Fig. 5).
Neutrophil Reactive Oxygen Species (ROS) Production in
Response to Yersinia
PMN externalization of PS and apoptosis are associated with
ROS production [6–8,37,38]. We showed previously that Y. pestis
strain KIM6 induces rapid PMN ROS production, whereas KIM5
completely inhibits ROS production in human PMNs [32]. To test
whether YopJ/YopP play a role in ROS inhibition, PMN ROS
was measured following phagocytic interaction with KIM5 YopJ-
YopP and KIM5DyopJ. KIM5 YopJ-YopP and KIM5DyopJ were
found to inhibit PMN ROS production as effectively as KIM5 and
Y. enterocolitica (Fig. 6a). Since incubation of PMNs with KIM5
resulted in inhibition of PMN ROS production (Fig. 6a) and a
decrease in LDH release and EthD-1 staining (Fig. 4), we assessed
the contribution of ROS production to PMN cell death. Inhibition
of Y. pestis KIM6-mediated PMN ROS production with the
NADPH oxidase inhibitor DPI was similar to that observed
following neutrophil interaction with Y. pestis KIM5 (Fig. 6b). In
addition, PMNs pretreated with DPI and incubated with KIM6
had decreased levels of LDH release and EthD-1 staining
compared to PMN controls incubated with KIM6 (Fig. 6c and
6d, e.g., 42.266.6% LDH release and 24.061.7% EthD-1
Figure 2. Induction of caspase activity is YopJ/YopP dependent but delayed in human MDMs compared to J774A.1 cells. HMDMs and
J774A.1 cells were incubated alone or with Y. pestis KIM5, KIM5 YopJ-YopP, KIM5DyopJ, KIM6 and Y. enterocolitica 8081v grown at 37uC. Caspase-3, -8,
-9, and -2 activity was measured after 6 h of incubation as described in Materials and Methods and is expressed in relative fluorescence units (RFLU).
Results are expressed as the mean 6 SEM of three experiments. *, represents difference from HMDM and J774A.1 controls (P,0.05).
doi:10.1371/journal.pone.0009279.g002
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staining at 48 h, respectively). Thus, inhibition of ROS production
by DPI following 48 h incubation with KIM6 decreased PMN
LDH release by ,23.4% and EthD-1 staining by ,22.8%.
Further, PMN cell death decreased following inhibition of
neutrophil ROS production with either DPI or the Y. pestis type
III secretion system (Fig. 6c and 6d).
Discussion
The role of Yersinia YopJ and YopP in murine macrophage and
dendritic cell death is well described [19–27]. Notwithstanding,
the contribution of Yersinia and the role of YopJ and YopP in
induction of cell death in human PMNs and HMDMs is less clear.
PMNs account for ,70% of the circulating leukocytes in humans
and, along with macrophages, are rapidly recruited to sites of
infection where they act to eliminate most invading pathogens [2].
Previous studies show that Yersinia expressing YopP are highly
cytotoxic to murine macrophages and dendritic cells; however, it
was recently demonstrated that amino acid sequence differences
between YopJ and YopP result in YopJ being translocated into
host cells less efficiently [28,29]. Consequently, Yersinia expressing
YopJ are less cytotoxic to J774A.1 cells and dendritic cells than
those expressing YopP [28,29]. Additionally, Yersinia engineered to
express YopP (instead of YopJ) are less pathogenic to mice via oral
[28] or subcutaneous infection [30]. However, Y. pestis virulence is
maintained following expression of YopP in intravenous and
intranasal murine infection models [30] and thus may be involved
in transmission. Notwithstanding, these results provide evidence
that Y. pestis has evolved, at least in part, to limit host innate
immune cell apoptosis/cytotoxicity and further demonstrate the
importance of understanding host innate immune cell fate
following interaction with Yersinia.
PMNs are intimately associated with acute inflammation [9],
and premature lysis potentiates destruction of host tissue [39].
Based on this premise, at least in part, we investigated the role of
Yersinia YopJ and YopP in the determination of cell fate in human
PMNs. To account for translocation efficiency differences and to
analyze YopJ and YopP effects more thoroughly, we created a Y.
pestis strain expressing YopP in place of YopJ on the native pCD1
virulence plasmid with minimal disruption (KIM5 YopJ-YopP). In
macrophages, YopP was the more potent inducer of cell death,
although under our assay conditions with synchronized close
Figure 3. Role of YopJ and YopP in human PMN cell death. PMNs were incubated alone or with Y. pestis KIM5, KIM5 YopJ-YopP, KIM5DyopJ,
KIM6 and Y. enterocolitica 8081v grown at 37uC. The percentage of PMN cell death following incubation with each strain for the indicated time was
determined by comparison to detergent lysed controls. Indicators of cell death measured were release of (A) LDH into the supernatant and (B) EthD-
1 uptake into PMN cells as described in Materials and Methods. Results are expressed as the mean 6 SEM of three experiments. *, represents
difference from PMN controls (P,0.05).
doi:10.1371/journal.pone.0009279.g003
Figure 4. Analysis of PMN phosphatidylserine (PS) external-
ization. Y. pestis KIM5, KIM5 YopJ-YopP, KIM5DyopJ, KIM6 and Y.
enterocolitica were grown at 37uC, combined with PMNs, and
incubated for the times indicated. PS externalization was determined
by annexin V-FITC and flow cytometry following interaction with
Yersinia Results are expressed as the mean 6 SEM of at least
three experiments. *, represents difference from PMN controls
(P,0.05).
doi:10.1371/journal.pone.0009279.g004
Yersinia and PMN Cell Death
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also induced caspase activation, EthD-1 staining, and LDH release
(Fig. 1 and Fig. 2). Our data also indicate that Yersinia induced cell
death in HMDMs is similar (albeit delayed and less severe) to that
observed for J774A.1 cells (Fig. 1 and Fig. 2). The decreased
susceptibility of HMDMs to YopJ/YopP (Fig. 1 and Fig. 2) is in
agreement with previous Y. enterocolitica findings demonstrating that
HMDMs differentiated via colony-stimulating factor, and/or
prolonged incubation, exhibit delayed/decreased apoptosis rela-
tive to J774A.1 cells [26,40]. Nonetheless, we found that HMDM
and J774A.1 cell death was dependent on YopJ/YopP expression
as indicated by severe membrane disruption and release of
cytosolic components (Fig. 1 and Fig. 2). By contrast, incubation of
Yersinia with PMNs yielded drastically different results than those
observed with macrophages. Interaction of neutrophils with any of
the virulence plasmid carrying Yersinia strains did not result in
YopJ/YopP induced LDH release, or EthD-1 staining (Fig. 3).
However, PMNs incubated with KIM6 lacking a virulence
plasmid resulted in increased late PMN LDH release and EthD-
1 staining (Fig. 3). Unlike caspase activation observed in
macrophages, neither caspase-3, -8, -9, nor -2 activity increased
in PMNs incubated with Yersinia, indicating that YopJ/YopP did
not directly activate the PMN apoptotic pathway (Fig. 5).
PMN apoptosis is associated with increased ROS production
[4,8]. PMNs from chronic granulomatous disease (CGD) patients
(NADPH oxidase-deficient) or PMNs treated with DPI (NADPH
oxidase inhibitor) exhibit delayed apoptosis in the presence of TNF-
a and bacteria [4,8,36,41]. Furthermore, treatment of PMNs with
phorbolmyristate acetate (induces robust ROS production), accel-
erates apoptosis; however, increased levels of ROS inhibit PMN
caspase activity [7,42,43]. The significance of PMN ROS
production following interaction with microbial pathogens in vivo
was demonstrated in CGD mice in which PMNs fail to externalize
PS and undergo apoptosis after infection with pathogens [38]. As a
result, PMNs are not cleared from the site of infection, thus
increasing S. aureus pathogenicity [38]. Previous Yersinia studies have
shown that KIM5 and Y. enterocolitica rapidly and efficiently inhibit
PMN ROS production [32,44], whereas KIM6 stimulates a
pronounced ROS response [32]. We found that KIM5 YopJ-YopP
and KIM5DyopJ are able to inhibit neutrophil ROS production as
efficiently as KIM5 and Y. enterocolitica (Fig. 6a). Inhibition of PMN
ROS production by virulence plasmid-containing Yersinia strains
Figure 5. Caspase-3, -8, -9, and -2 activity in PMNs following incubation with Yersinia. PMNs were incubated alone or with Y. pestis KIM5,
KIM5 YopJ-YopP, KIM5DyopJ, KIM6 and Y. enterocolitica 8081v grown at 37uC. Caspase-3, -8, -9, and -2 activity was measured after 3 h and 6 h of
incubation as described in Materials and Methods and is expressed in relative fluorescence units. Results are expressed as the mean 6 SEM of three
experiments. *, represents difference from PMN controls (P,0.05).
doi:10.1371/journal.pone.0009279.g005
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subsequent LDH release and EthD-1 staining (Fig. 3) following
incubation of Yersinia with PMNs. We found that DPI-inhibition of
PMN ROS production during phagocytic interaction with Y. pestis
KIM6 reduced the amount of LDH release and EthD-1 staining
(Fig. 6). Thus, our data indicate that ROS contribute to PMN cell
death in part, and that Yersinia TTSS-dependent inhibition of ROS
production delays normal PMN apoptosis.
Overall, our data show that YopJ/YopP-mediated induction of
apoptosis does not occur in PMNs in contrast to observations with
macrophages. Incubation of KIM5, Y. enterocolitica, KIM5 YopJ-
YopP, or KIM5DyopJ with PMNs resulted in decreased PMN
exposure of PS, ROS production, LDH release, and EthD-1 staining
compared to that of KIM6 (Figs. 3–4, and Fig. 6). On the other hand,
PMN interaction with Y. pestis strain KIM6 resulted in both apoptosis
and cell lysis, which was reduced to KIM5 levels after DPI treatment.
These findings suggest that Yersinia virulence plasmid-dependent, but
YopJ/YopP-independent, inhibition of ROS production alters
normal PMN PICD [4, 6–8]. Pathogen-mediated delay of PMN
apoptosis and lysis would plausibly decrease the host inflammatory
response, relative to that required for resolution of infection, and
facilitateYersinia pathogenesis.This proposed mechanism is consistent
with recent findings that demonstrate that increased immune cell
cytotoxicity/apoptosis corresponds to attenuation of Yersinia virulence
[28,30]. Further studies are required to elucidate in vivo the impact of
Y. pestis on PMNcytokine production,cellfate, and subsequentlyhow
altering PICD affects the overall acute inflammatory response during
Yersinia infection.
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